Diphosphopyridine nucleotide in the treatment of schizophrenia

JAMA. 1967 Jun 5;200(10):881-2.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Humans
  • Middle Aged
  • NAD / therapeutic use*
  • Placebos
  • Schizophrenia / drug therapy*
  • Tablets, Enteric-Coated

Substances

  • Placebos
  • Tablets, Enteric-Coated
  • NAD